Literature DB >> 15743781

Relationship of acute lung inflammatory injury to Fas/FasL system.

Thomas A Neff1, Ren-Feng Guo, Simona B Neff, J Vidya Sarma, Cecilia L Speyer, Hongwei Gao, Kurt D Bernacki, Markus Huber-Lang, Stephanie McGuire, L Marco Hoesel, Niels C Riedemann, Beatrice Beck-Schimmer, Firas S Zetoune, Peter A Ward.   

Abstract

There is mounting evidence that apoptosis plays a significant role in tissue damage during acute lung injury. To evaluate the role of the apoptosis mediators Fas and FasL in acute lung injury, Fas (lpr)- or FasL (gld)-deficient and wild-type mice were challenged with intrapulmonary deposition of IgG immune complexes. Lung injury parameters ((125)I-albumin leak, accumulation of myeloperoxidase, and wet lung weights) were measured and found to be consistently reduced in both lpr and gld mice. In wild-type mice, lung injury was associated with a marked increase in Fas protein in lung. Inflamed lungs of wild-type mice showed striking evidence of activated caspase-3, which was much diminished in inflamed lungs from lpr mice. Intratracheal administration of a monoclonal Fas-activating antibody (Jo2) in wild-type mice induced MIP-2 and KC production in bronchoalveolar lavage fluids, and a murine alveolar macrophage cell line (MH-S) showed significantly increased MIP-2 production after incubation with this antibody. Bronchoalveolar lavage fluid content of MIP-2 and KC was substantially reduced in lpr mice after lung injury when compared to levels in wild-type mice. These data suggest that the Fas/FasL system regulates the acute lung inflammatory response by positively affecting CXC-chemokine production, ultimately leading to enhanced neutrophil influx and tissue damage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15743781      PMCID: PMC1602343          DOI: 10.1016/S0002-9440(10)62290-0

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  45 in total

Review 1.  Fas ligand-induced apoptosis.

Authors:  S Nagata
Journal:  Annu Rev Genet       Date:  1999       Impact factor: 16.830

2.  Fas/FADD-mediated activation of a specific program of inflammatory gene expression in vascular smooth muscle cells.

Authors:  F J Schaub; D K Han; W C Liles; L D Adams; S A Coats; R K Ramachandran; R A Seifert; S M Schwartz; D F Bowen-Pope
Journal:  Nat Med       Date:  2000-07       Impact factor: 53.440

3.  Upregulation of two death pathways of perforin/granzyme and FasL/Fas in septic acute respiratory distress syndrome.

Authors:  S Hashimoto; A Kobayashi; K Kooguchi; Y Kitamura; H Onodera; H Nakajima
Journal:  Am J Respir Crit Care Med       Date:  2000-01       Impact factor: 21.405

4.  Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis.

Authors:  K Kuwano; N Hagimoto; M Kawasaki; T Yatomi; N Nakamura; S Nagata; T Suda; R Kunitake; T Maeyama; H Miyazaki; N Hara
Journal:  J Clin Invest       Date:  1999-07       Impact factor: 14.808

5.  Improved prognosis of acute respiratory distress syndrome 15 years on.

Authors:  F Jardin; J L Fellahi; A Beauchet; A Vieillard-Baron; Y Loubières; B Page
Journal:  Intensive Care Med       Date:  1999-09       Impact factor: 17.440

6.  Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS).

Authors:  G Matute-Bello; W C Liles; K P Steinberg; P A Kiener; S Mongovin; E Y Chi; M Jonas; T R Martin
Journal:  J Immunol       Date:  1999-08-15       Impact factor: 5.422

7.  Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD.

Authors:  L Segura-Valdez; A Pardo; M Gaxiola; B D Uhal; C Becerril; M Selman
Journal:  Chest       Date:  2000-03       Impact factor: 9.410

8.  Induction of interleukin-8 secretion and apoptosis in bronchiolar epithelial cells by Fas ligation.

Authors:  N Hagimoto; K Kuwano; M Kawasaki; M Yoshimi; Y Kaneko; R Kunitake; T Maeyama; T Tanaka; N Hara
Journal:  Am J Respir Cell Mol Biol       Date:  1999-09       Impact factor: 6.914

9.  The involvement of Fas-Fas ligand pathway in fibrosing lung diseases.

Authors:  K Kuwano; H Miyazaki; N Hagimoto; M Kawasaki; M Fujita; R Kunitake; Y Kaneko; N Hara
Journal:  Am J Respir Cell Mol Biol       Date:  1999-01       Impact factor: 6.914

10.  Evidence for the involvement of Fas ligand and perforin in the induction of vascular leak syndrome.

Authors:  A Q Rafi; A Zeytun; M J Bradley; D P Sponenberg; R L Grayson; M Nagarkatti; P S Nagarkatti
Journal:  J Immunol       Date:  1998-09-15       Impact factor: 5.422

View more
  35 in total

Review 1.  The role of complement in danger sensing and transmission.

Authors:  Jörg Köhl
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

2.  The biological activity of FasL in human and mouse lungs is determined by the structure of its stalk region.

Authors:  Raquel Herrero; Osamu Kajikawa; Gustavo Matute-Bello; Yi Wang; Naoki Hagimoto; Steve Mongovin; Venus Wong; David R Park; Nathan Brot; Jay W Heinecke; Henry Rosen; Richard B Goodman; Xiaoyun Fu; Thomas R Martin
Journal:  J Clin Invest       Date:  2011-03       Impact factor: 14.808

3.  Fas (CD95) induces macrophage proinflammatory chemokine production via a MyD88-dependent, caspase-independent pathway.

Authors:  William A Altemeier; Xiaodong Zhu; William R Berrington; John M Harlan; W Conrad Liles
Journal:  J Leukoc Biol       Date:  2007-06-18       Impact factor: 4.962

4.  Sodium hydrosulfide alleviates lung inflammation and cell apoptosis following resuscitated hemorrhagic shock in rats.

Authors:  Dun-quan Xu; Cao Gao; Wen Niu; Yan Li; Yan-xia Wang; Chang-jun Gao; Qian Ding; Li-nong Yao; Wei Chai; Zhi-chao Li
Journal:  Acta Pharmacol Sin       Date:  2013-10-14       Impact factor: 6.150

5.  Fas determines differential fates of resident and recruited macrophages during resolution of acute lung injury.

Authors:  William J Janssen; Lea Barthel; Alaina Muldrow; Rebecca E Oberley-Deegan; Mark T Kearns; Claudia Jakubzick; Peter M Henson
Journal:  Am J Respir Crit Care Med       Date:  2011-09-01       Impact factor: 21.405

6.  Differential role of the Fas/Fas ligand apoptotic pathway in inflammation and lung fibrosis associated with reovirus 1/L-induced bronchiolitis obliterans organizing pneumonia and acute respiratory distress syndrome.

Authors:  Andrea D Lopez; Sreedevi Avasarala; Suman Grewal; Anuradha K Murali; Lucille London
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

Review 7.  Cell Death in the Lung: The Apoptosis-Necroptosis Axis.

Authors:  Maor Sauler; Isabel S Bazan; Patty J Lee
Journal:  Annu Rev Physiol       Date:  2018-11-28       Impact factor: 19.318

8.  Fas (CD95) induces rapid, TLR4/IRAK4-dependent release of pro-inflammatory HMGB1 from macrophages.

Authors:  Feng Wang; Ziyue Lu; Michael Hawkes; Huan Yang; Kevin C Kain; W Conrad Liles
Journal:  J Inflamm (Lond)       Date:  2010-06-17       Impact factor: 4.981

9.  Kidney ischemia-reperfusion injury induces caspase-dependent pulmonary apoptosis.

Authors:  Heitham T Hassoun; Mihaela L Lie; Dmitry N Grigoryev; Manchang Liu; Rubin M Tuder; Hamid Rabb
Journal:  Am J Physiol Renal Physiol       Date:  2009-04-29

10.  Ethyl pyruvate reduces mortality in an endotoxin-induced severe acute lung injury mouse model.

Authors:  Guan-Hong Shang; Dian-Jie Lin; Wei Xiao; Chong-Qi Jia; Yu Li; Ai-Hua Wang; Liang Dong
Journal:  Respir Res       Date:  2009-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.